Related Experiment Video
Updated: Jul 9, 2026
06:32
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Molecular and genetic profiling in human gliomas
Kamalakannan Palanichamy1, Michael Erkkinen, Gregory Saia
1Department of Radiation Oncology, Massachusetts General Hospital/Harvard Medical School, 100 Blossom Street, Cox 3, Boston, MA 02114, USA.
Discovery Medicine
|December 21, 2007
Summary
Glioblastoma multiforme, a deadly brain tumor, has limited treatment options. Molecular and genetic profiling are advancing understanding of its progression and resistance, paving the way for new therapies.
Area of Science:
- Neuro-oncology
- Cancer Genomics
- Molecular Pathology
Background:
- Glioblastoma multiforme (GBM) is the most aggressive primary brain tumor.
- Current treatments offer limited survival benefits for GBM patients.
- The tumor's complexity and heterogeneity present significant therapeutic challenges.
Purpose of the Study:
- To highlight advances in understanding glioblastoma multiforme.
- To underscore the importance of molecular and genetic profiling in GBM research.
- To emphasize the potential for novel therapeutic development.
Main Methods:
- Review of current literature on glioblastoma multiforme.
- Analysis of molecular and genetic profiling techniques.
- Synthesis of findings related to disease progression and therapeutic resistance.
Main Results:
- Molecular and genetic profiling have identified key mechanisms driving GBM progression.
- These profiling techniques reveal insights into therapeutic resistance in GBM.
- Advances facilitate the identification of potential therapeutic targets.
Conclusions:
- Molecular and genetic profiling are crucial for advancing glioblastoma research.
- Understanding GBM complexity is key to developing more effective treatments.
- These advances offer hope for improved patient outcomes in glioblastoma.
